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Background: Direct-to-patient research via Web-based questionnaires is increasingly being used. Missed data or delayed
reporting of data may negatively affect the quality of study results. It is insufficiently known to what degree patients adhere to
agreed self-assessment schedule over the long term and whether questionnaires are filled out in a timely manner.
Objective: The objective of this study was to investigate patients’ adherence to a self-assessment schedule with low-frequency
long questionnaires versus that with a high-frequency short questionnaire.
Methods: In this study, the 36-item MS Impact Profile (MSIP) questionnaire measured (perceived) disabilities and the 54-item
MS Quality of Life-54 (MSQoL-54) questionnaire measured health-related quality of life at 6-month intervals. Additionally, the
2-item Medication and Adherence (MA) questionnaire documented medication and adherence to disease-modifying medication
every month. An experienced MS nurse assessed the Expanded Disability Status Scale (EDSS) score via phone. For both the
self-assessment schedules, we calculated the percentage of patients who had completed all the questionnaires in the first 2 years
(completion adherence), the percentage of patients who completed all the questionnaires within set time frames (interval adherence),
the relationship between adherence and the EDSS score, and the timing of EDSS assessment.
Results: Of the 331 patients who enrolled themselves, 301 patients completed at least one questionnaire. At month six (M6),
M12, M18, and M24, the MSIP was completed by 83.4% (251/301), 71.8% (216/301), 68.1% (205/301), and 58.5% (176/301)
of the patients, respectively; the MSQoL-54 by 82.1% (247/301), 71.8% (216/301), 66.8% (201/301), and 57.1% (172/301),
respectively; and the MA questionnaire by 80.1% (241/301), 70.4% (212/301), 62.1% (187/301), and 53.5% (161/301), respectively.
For the MSIP, 56.8% (171/301) of the patients were 2-year completion adherent; 55.5% (167/301) and 53.5% (161/301) of the
patients were completion adherent for the MSQoL-54 and MA questionnaires, respectively. Whereas 85.5% (142/166) of the
patients were interval adherent for the MSIP and MSQoL-54, 25.5% (41/161) were interval adherent for the MA questionnaire,
with 73.9% (119/161) exceeding the maximum MA monthly interassessment interval. Completion adherence for the monthly
short MA questionnaire was higher in patients with moderately high disability (EDSS 5.0-5.5) than for those with no or minimal
disability (EDSS 0-2.5) (OR 5.47, 95% CI 1.08-27.69; P=.040). Completion adherence was also higher in patients with EDSS
assessment within 6 months after baseline than in those with later assessment (OR 1.810, 95% CI 0.999-3.280; P=.050).
Conclusions: The 2-year completion adherence to Web-based self-assessments did not differ between the low-frequency long
questionnaires and a high-frequency short questionnaire, but the interval adherence was substantially higher for the low-frequency
J Med Internet Res 2017 | vol. 19 | iss. 7 | e249 | p.1http://www.jmir.org/2017/7/e249/
(page number not for citation purposes)
Jongen et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
long questionnaires. Personal contact with a member of the research team regarding a clinically relevant professional-reported
outcome early in the study might positively affect the long-term completion adherence in direct-to-patient studies.
(J Med Internet Res 2017;19(7):e249)   doi:10.2196/jmir.6729
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Introduction
Multiple sclerosis (MS) is a chronic inflammatory demyelinating
and degenerative disease of the central nervous system, mainly
affecting persons in young adulthood. In about 80% of the
patients, the first phase is characterized by a pattern of recurrent
episodes of symptoms (relapses), typically followed by complete
or partial remissions. This phase of MS is referred to as relapsing
remitting MS (RRMS) [1]. Although disease-modifying drugs
(DMDs) reduce the frequency and severity of relapses, after
about 20 years, most persons with RRMS progress to the
secondary progressive (SP) phase, experiencing a steady and
unstoppable increase in disability [2,3]. In about 10% to 15%
of the patients, symptoms start insidiously and develop slowly
without relapses. This form of MS is referred to as primary
progressive MS (PPMS) [1]. In both SPMS and PPMS, the
continuous increase in disability results mainly from
degenerative processes. The multifocal localization of the lesions
accounts for the wide variety of symptoms that may arise in the
course of the disease; these symptoms often interfere with
physical, cognitive, social, or occupational activities. Over the
long term, the MS-related disabilities often represent a
substantial burden to the patients and their environment.
To enable neurologists to better prognosticate the disease course
in individual patients, they need to be informed in more detail
about the degree of and variation in long-term disabilities. To
obtain this information, patient-reported outcomes (PROs) are
increasingly being used in addition to physician-based measures
such as the Expanded Disability Status Scale (EDSS). A PRO
is any report of the status of a patient’s health condition that
comes directly from the patient, without interpretation of the
patient’s response by a clinician or anyone else [4]. A PRO that
is increasingly being used in clinical research is health-related
quality of life (HRQoL), an overall measure of well-being from
a patient’s perspective that provides a comprehensive measure
of health status [5].
The Internet has empowered patients to directly participate in
research projects without the involvement of their physician or
physician’s setting [6,7]. The rapid adoption of the Internet by
MS patients, the limited costs of Web-based contacts, and the
easy access to large numbers of potential participants are all in
favor of a direct-to-patient study design [6,8]. The data that can
thus be obtained include PROs on various symptoms,
(perceived) disabilities, HRQoL, and treatment, and these data
may complement neurologist- or nurse-reported data about
diagnosis, disease course, and magnetic resonance imaging [6].
In view of the scarcity of long-term data on (perceived)
disabilities and HRQoL in MS patients in the Netherlands, we
conceived the prospective, direct-to-patient, interactive, Dutch
MS study [9]. The study participants enrolled themselves and
agreed to complete two long questionnaires on (perceived)
disabilities (36 items) and HRQoL (54 items) at 6-month
intervals and a short questionnaire on medication and adherence
to DMD treatment (two items) at monthly intervals [9].
One of the crucial aspects of long-term direct-to-patient research
is the participants’ adherence to the predetermined assessment
schedule. A reduction in the amount of data that patients provide
may seriously affect the validity and meaningfulness of the
study results [10,11]. Conceivably, the same amount of data
can be acquired by the infrequent use of long questionnaires or
the frequent use of short questionnaires. In fact, different factors
might determine the adherence to a self-assessment schedule:
a high-frequency short questionnaire could be bothersome to
patients due to the frequent interference with their daily life or
frequent confrontation with their disabilities and limitations,
whereas a low-frequency long questionnaire might be
cumbersome because of requiring more time to complete, and
thus, potentially increasing MS-related fatigue.
In a previous patient-centered Web-based study involving
RRMS patients who were included by their neurologists, we
investigated the adherence to monthly Web-based
self-assessments after the start of DMD treatment [12]. It was
found that 75.5% of the patients completed two short
questionnaires at all monthly time points over the course of 1
year, although only 1 in 5 patients adhered to the monthly
intervals between consecutive self-assessments [12]. To gain
information about the long-term adherence of MS patients to
low-frequency completions of long questionnaires versus
high-frequency completions of short questionnaires in a
direct-to-patient research setting, this study analyzed the 2-year
adherence data in the Dutch MS study [9]. Given the study
design, participation in this study was not a priori integrated
into patient care. As the embedding of research activities in care
processes may positively affect patient adherence and adherence
may decrease over time, it was hypothesized that at least for the
high-frequency short questionnaire, the 2-year completion
adherence would be less than 75%.
Methods
Dutch Multiple Sclerosis Study
The Dutch MS study is a prospective, Web-based,
direct-to-patient, interactive study of long-term disabilities,
perception of disabilities, and HRQoL in patients with MS in
the Netherlands. The innovative study design is characterized
by Web-based patient-driven enrollment, Web-based data
acquisition, the use of PROs, and the use of personal study data
by patients and authorized health care professionals for
self-assessment and assessment, self-monitoring and monitoring,
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or multidisciplinary care. The objectives of the study, design,
target population, recruitment, ethical aspects, data acquisition,
technical aspects, outcome measures, assessment schedule,
organization, and funding have been described in detail
elsewhere [9].
Patients were informed about the study via websites of three
patient organizations and of the MS4 Research Institute [13].
By regular mail, neurologists and MS nurses were sent an
informative letter with patient brochures, which they were asked
to hand out to their patients. The brochure was also sent to the
patrons of the National MS Foundation, the Netherlands, as an
attachment to the foundation’s quarterly journal and related
mailings. In the journal, study information was presented by
the principal investigator (PJ). Information about the study was
published twice in health specials of large national and regional
Dutch newspapers. The protocol was submitted to the Ethics
Committee Medisch Ethische Toetsing Onderzoek Patiënten en
Proefpersonen in Tilburg, the Netherlands (nr M379). The
committee concluded that a review was not indicated, as the
study did not qualify for being tested according to the Dutch
Medical Research Involving Human Subjects Act [14,15]. The
study is being conducted in agreement with the Declaration of
Helsinki (Ethical Principles for Medical Research Involving
Human Subjects version 2013; 64th World Medical Association
General Assembly, Fortaleza, Brazil, October 2013) [16], and
the Dutch Medical Research Involving Human Subjects Act
[15].
Technically, the study is a modular application on the Curavista
eHealth platform (Curavista bv, Geertruidenberg, the
Netherlands), built on an Oracle database with Java-scripting,
XML-applets, and AJAX protocols (Oracle Corporation,
Redwood City, CA). Data processing is 256-bit encrypted with
virtual private network tunneling. The databases and software
are physically secured in a dedicated data center in the
Netherlands [9]. On the day of the scheduled assessment,
patients receive a notification by an email indicating that a
questionnaire is available for completion. If the questionnaire
is not completed on the scheduled date, reminders are sent after
4 and 7 days.
Disabilities, perceptions of disabilities, and HRQoL are
measured every 6 months via the Multiple Sclerosis Impact
Profile (MSIP) and the Multiple Sclerosis Quality of Life-54
(MSQoL-54) questionnaires. The MSIP is made available first
and the MSQOL-54 one week later. The medication that is being
taken and the adherence to DMD treatment are secondary
outcomes; these are measured every month via the Medication
and Adherence (MA) questionnaire. Every 6 months, the
completion of the MA questionnaire coincides with the
completion of the MSIP and MSQoL-54. The completion of
the combined MSIP and MSQoL-54 takes about 30 to 45 min;
completion of the MA questionnaire takes less than 5 min.
Questionnaires
Multiple Sclerosis Impact Profile
The MSIP is a measure of MS-related disabilities and perception
of disabilities with established psychometric properties [17,18].
It is based on the International Classification of Functioning,
Disability and Health and reflects an objectified view of the
prevalence and severity of the impact of MS. The MSIP
comprises 36 questions assessing disability (Q1a-Q36a) and
perception of disability (Q1b-Q36b) in the following domains:
muscle and movement functions; excretion and reproductive
functions; activities involving basic movements; activities of
daily living; participation in life situations; environmental
factors; mental functions; and the symptoms fatigue, pain,
speech, and vision [17,18].
Multiple Sclerosis Quality of Life-54
HRQoL is assessed with the MSQoL-54 questionnaire, a
psychometrically validated MS-specific multidimensional
inventory of patient-centered health status [19]. The MSQoL-54
consists of the 36-item Short Form health survey as a generic
core measure to enable comparisons with other patient
populations and to the general population, supplemented with
18 additional questions exploring items relevant to MS patients
in the areas of health distress (four items), sexual function (four
items), satisfaction with sexual function (one item), overall
quality of life (two items), cognitive function (four items),
energy (one item), pain (one item), and social function (one
item) [19].
Medication and Adherence Questionnaire
The MA questionnaire gives an update of medications that are
taken, the number of DMD doses missed in the past month, and
the date and reason of DMD discontinuation (if applicable).
Disability Assessment by Phone
The EDSS is a widely used disability measure in MS. The EDSS
quantifies disability in eight functional systems and allows
neurologists and qualified nurses to assign a functional system
score in each of these systems [20]. The functional systems are
as follows: pyramidal, cerebellar, brainstem, sensory, bowel
and bladder, visual, cerebral, and other. The EDSS steps 0.0 to
4.5 refer to MS patients who are fully ambulatory, and EDSS
steps 5.0 to 9.5 are defined by the impairment to ambulation.
A version of the EDSS that can be used as a structured interview
by phone and has been validated for serial assessments in a
research setting was used in the Dutch MS study [21,22]. All
patients were sent an email in which they were asked if they
agreed to a disability assessment via an interview by phone.
The emails were sent in order of enrollment. If patients agreed,
they were asked to provide information about the days of the
week and the time of the day they were available for the
assessment by phone. Patients were free regarding when to
contact the study team and when to schedule the EDSS
interview. In addition to answering the questions of the
structured interview during the phone contact, the patients had
the opportunity to ask study-related information or discuss study
aspects with the assessing researcher, an experienced nurse
specialized in MS.
Study Outcomes
The outcomes of this analysis are the adherence to the
assessment schedules of the MSIP, MSQoL-54, and MA
questionnaires during the first 2 years of the study. Regarding
the MSIP and the MSQoL-54, patients were classified as
completion adherent for the respective questionnaire if they had
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performed all five scheduled 6-month assessments during the
first 2 years. Patients were classified as completion adherent
for the MA questionnaire if they had performed all scheduled
monthly assessments during the first 2 years. Patients were
classified as overall completion adherent if they had performed
all scheduled MSIP, MSQoL-54, and MA assessments in this
period.
Patients who were completion adherent for the MSIP or
MSQoL-54 were classified as interval adherent if they met the
following three criteria: (1) median interassessment interval
was 180+10 days or less, (2) maximum interassessment interval
was 180+20 days or less, and (3) month 24 (M24) completion
was within 30 days after the scheduled date. Patients who were
completion adherent for the MA questionnaire were classified
as interval adherent if (1) the median interassessment interval
was 30+3 days or less, (2) the maximum interassessment interval
was 30+6 days or less, and (3) the M24 completion was within
30 days after the scheduled date.
Statistical Analysis
The numbers of patients who completed the respective
questionnaires at the various time points were calculated, as
well as the intervals between two consecutive assessments and
between the baseline and M24 assessment. The intervals
between two consecutive assessments (days) were presented as
mean, standard deviation (SD), median, minimum, maximum,
and interquartile range (IQR). Friedman’s analysis of variance
and the Wilcoxon signed-rank test were used to test whether
the intervals for consecutive time points differed between the
MSQoL-54, MSIP, and MA questionnaires. The numbers of
patients who were completion- or interval adherent are expressed
as the percentage of patients who actually started participating
in the study by completing at least one of the questionnaires.
To compare the completion adherence rates and interval
adherence rates of the three questionnaires, Cochran’s Q test
was performed. To test for significant associations between sex,
age, EDSS score, and the timing of EDSS assessment on the
one hand, and completion adherence and interval adherence
regarding the low-frequency long questionnaires (MSIP,
MSQoL-54) and the high-frequency short questionnaire (MA)
on the other hand, we used logistic regression analysis. All tests
were performed in Statistical Package for the Social Sciences
for Windows version 24 (IBM Corporation, Armonk, NY).
The EDSS score was categorized into no to minimal disability
(scores 0-2.5), fully ambulatory with moderate disabilities
(scores 3.0-3.5), fully ambulatory with little to moderate effect
on daily activities (scores 4.0-4.5), ability to walk about 100 to
200 m without aid and fully or severely impaired in performing
daily activities (scores 5.0-5.5), ability to walk about 20 to 100
m with aid (scores 6.0-6.5), and severely disabled in walking
or fully restricted to bed or chair (scores above 7.0). The timing
of EDSS assessment by phone was dichotomized into assessment
within 6 months after baseline self-assessment and later than 6




A total of 331 patients had enrolled themselves in the study at
least 2 years before the date of analysis (July 2015), from March
23, 2011 to March 15, 2012. Of these, 301 (90.94%) had actually
started participating in the study by completing at least one
questionnaire at baseline, whereas 30 (9.06%) patients had
effectively not started participation. Of the 331 patients, 246
(74.32%) were female, 67 (20.24%) were male, and for 18
(5.40%) the sex was unknown. The mean age was 45.59 (SD
11.05) years, the median was 45.13, the minimum was 17.18,
the maximum age was 70.57, and the IQR was 37.82-53.92
(N=310). Of the 301 patients who had completed at least one
questionnaire at baseline, 234 (77.74%) were female and 67
(22.25%) were male. The mean age was 45.52 (SD 11.08), the
median was 44.96, the minimum was 17.18, the maximum was
70.57, and the IQR was 37.82-53.92 (N=298).
Completions
The numbers and percentages of patients who completed the
MSIP at baseline, M6, M12, M18, and M24 were 296 (98.3%),
251 (83.4%), 216 (71.8%), 205 (68.1%), and 176 (58.5%),
respectively, and the numbers and percentages of patients who
completed the MSQoL-54 at baseline, M6, M12, M18, and M24,
were 281 (93.4%), 247 (82.1%), 216 (71.8%), 201 (66.8%), and
172 (57.1%), respectively (Figure 1). The numbers and
percentages of patients who completed both these questionnaires
at baseline, M6, M12, M18, and M24 were 281 (93.4%), 247
(82.1%), 215 (71.4%), 199 (66.1%), and 171 (56.8%),
respectively (Figure 1).
Figure 2 shows the numbers of patients who had completed the
MA questionnaire at various time points, expressed as the
percentage of patients (N=301) who had started study
participation. The numbers of patients who had completed the
MA questionnaire at baseline, M6, M12, M18, and M24 were
301 (100%), 241 (80.1%), 212 (70.4%), 187 (62.1%), and 161
(53.5%), respectively.
Table 1 shows the numbers and percentages of patients who
completed the MA questionnaire at all 25 time points, at 24 to
one time point(s), or at no time point, irrespective of these being
consecutive assessments.
The numbers and percentages of patients who completed the
respective questionnaires at baseline and at M6, M12, M18, and
M24 (five time points) at four, three, two, or one time point(s),
or at no time point, irrespective of these being consecutive
assessments, are shown in Table 2.
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Table 1. Numbers and percentages of patients who completed the short Medication and Adherence questionnaire at all 25 time points, at 24 to one time
point(s), or at no time point, irrespective of these being consecutive assessments (N=301).



























Table 2. Numbers and percentages of patients who completed the Multiple Sclerosis Impact Profile, Multiple Sclerosis Quality of Life-54, and Medication
and Adherence questionnaires at baseline and at 6, 12, 18, and 24 months (five time points) at four, three, two, or one time point(s), or at no time point,
irrespective of these being consecutive assessments (N=301).
Medication and AdherenceMultiple Sclerosis
Quality of Life-54
Multiple Sclerosis Impact ProfileNumber of 6-month completions
n (%)n (%)n (%)
161 (53.5)167 (55.5)171 (56.8)5 (all)
187 (62.1)202 (67.1)203 (67.4)4
212 (70.4)219 (72.8)222 (73.8)3
241 (80.1)246 (81.7)252 (83.7)2
301 (100.0)283 (94.0)296 (98.3)1
3048350
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Figure 1. Percentages of patients who completed the Multiple Sclerosis Impact Profile and Multiple Sclerosis Quality of Life-54 questionnaires at
baseline and at 6, 12, 18, and 24 months (N=301).
Figure 2. Percentages of patients who completed the Medication and Adherence questionnaire at baseline and at the various monthly time points
(N=301).
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Table 3. Time intervals (days) between consecutive assessments.
M0-M24M18-M24M12-M18M6-M12M0-M6 Questionnaires
Multiple Sclerosis Quality of Life-54
724.05 (63.39)180.75 (27.89)180.25 (33.47)188.42 (37.20)177.82 (28.13)Mean (SDb)
10−41ª99−42ªMinimum
825257369545266Maximum
730 (729-733)183 (181-186)182 (181-184)183 (182-185)182 (180-184)Median (IQRc)
Multiple Sclerosis Impact Profile
733.23 (21.13)180.15 (28.27)179.73 (31.44)188.93 (34.69)186.39 (35.86)Mean (SD)
5470−32ª166114Minimum
852305374552738Maximum
731 (730-734)183 (181-185)182 (179-183.25)183 (182.25-187)183 (182-186)Median (IQR)
Medication and Adherence
763.75 (66.42)186.46 (47.43)220.67 (69.19)192.26 (49.86)188.10 (11.87)Mean (SD)
67510315089182Minimum 
1093370700550285Maximum 
749 (718-776)188 (152-200.5)197 (189-216)183 (180-188)185 (182-188)Median (IQR) 




The intervals (days) between two consecutive assessments and
between the baseline and M24 assessment (mean, SD, median,
minimum, maximum and IQR values) are given in Table 3.
Median values for the intervals between two consecutive
6-month assessments ranged from 182 to183 days for the
MSQoL-54 and the MSIP. The median time between baseline
and M24 was 730 days for the MSQoL-54 and 731 days for the
MSIP. For the MA questionnaire, the median values for
interassessment intervals ranged from 30 to 32 days and the
M24 assessment was at 749 days (median). The interval between
baseline and M6 significantly differed between the three
questionnaires (MSIP vs MSQoL-54: z=−5.37, P<.001;
MSQoL-54 vs MA: z=−8.73, P<.001; MSIP vs MA: z=−8.05,
P<.001), as did the M6-M12 interval between the MSIP and
MSQoL-54 (z=−2.42, P=.014) and the M12-M18 intervals
between MSQoL-54 and MA (z=−11.70, P<.001) and between
MSIP and MA (z=−11.44, P<.001) (see Multimedia Appendix
1). For the M18-M24 interval, no significant differences were
found between the three questionnaires. Significant differences
in time from baseline to M24 were found between all three
questionnaires (MSIP vs MSQoL-54: z=−4.04, P<.001;
MSQoL-54 vs MA: z=−6.17, P<.001; MSIP vs MA: z=−5.59,
P<.001).
Adherence to Low-Frequency Long Questionnaires
Of the 301 patients who started with the study, 166 (55.1%)
completed the MSIP and MSQoL-54 questionnaires at all five
time points, and they were therefore completion adherent for
the low-frequency long questionnaires. Of these, 159 (95.8%)
completed the M24 questionnaires within 30 days of the
scheduled date; 163 (98.2%) had a median interassessment
interval of 180+10 days or less, and 143 (86.1%) had a
maximum interassessment interval of 180+20 days or less. In
all, 85.5% (N=142) of the patients who were completion
adherent for the low-frequency long questionnaires were interval
adherent for these questionnaires.
Adherence to High-Frequency Short Questionnaire
Of the 301 patients who started participation, 161 (53.5%)
completed the MA questionnaire at all monthly time points and
were thus completion adherent for the high-frequency short
questionnaire. Of these, 99 (62%) performed the M24
assessment within 30 days of the scheduled date; 153 (95.0%)
had a median interassessment interval of 30+3 days or less; and
42 (26%) had a maximum interassessment interval of 30+6 days
or less. In all, 26% (N=41) of the patients who were completion
adherent for the high-frequency short questionnaire were interval
adherent for this questionnaire.
Overall Adherence
One hundred fifty-two (50.5%) patients were completion
adherent for both the low-frequency long questionnaires and
the high-frequency short questionnaire, and they were therefore
considered overall completion adherent. In addition, 36 (24%)
patients who were overall completion adherent were interval
adherent for both the low-frequency long questionnaires and
the high-frequency short questionnaire and were therefore
considered overall interval adherent. In all, 12% of the patients
who started with the study were overall completion and interval
adherent.
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The completion rates did not differ between the three
questionnaires (Cochran’s Q test: X2=5.630; P=.063). From the
above, it follows that 91.6% (152/166*100) of the patients who
were completion adherent for the low-frequency long
questionnaires were also completion adherent for the
high-frequency short questionnaire. Conversely, 94.4%
(152/161*100) of the patients who were completion adherent
for the high-frequency short questionnaire were also completion
adherent for the low-frequency long questionnaires. Moreover,
25% (36/142*100) of the patients who were interval adherent
for the low-frequency long self-assessments were also
completion adherent for the high-frequency short
self-assessments. Conversely, 88% (36/41*100) of those who
were interval adherent for the high-frequency short
self-assessments were also completion adherent for the
low-frequency long self-assessments.
There were no statistically significant differences between men
and women regarding the completion and interval adherence to
the low-frequency long questionnaires, the high-frequency short
questionnaire, or regarding the overall adherence rates. Likewise,
no association was found between age and adherence.
As for the EDSS, patients with an EDSS score of 5.0 or 5.5
were found to have higher odds of being completion adherent
for the high-frequency short questionnaire than patients with
an EDSS score of 0 to 2.5 (OR 5.47, 95% CI 1.08-27.69,
P=.040). Moreover, patients who had an EDSS assessment
within 6 months after baseline were more likely to be completion
adherent for the high-frequency short questionnaire than those
whose EDSS score was assessed later (OR 1.810, 95% CI
0.999-3.280, P=.050).
Discussion
In recent years, the direct-to-subject approach is being applied
increasingly in clinical studies, both in trials organized by
clinical research organizations and in investigator-driven
academic research [23,24]. This development is paralleled by
a growing number of studies that make use of the Internet for
the acquisition of patient-reported data. However, it is
insufficiently known to what degree patients who enroll
themselves in Web-based studies do indeed perform the
scheduled assessments and whether they do so on time,
especially over the long term. Such knowledge is relevant, as
patients who prematurely discontinue their participation or those
who provide data only infrequently or delayed may hamper the
validity of the study results.
To obtain insight into patients’ long-term adherence to a
self-assessment schedule in a setting of Web-based
direct-to-patient research, we analyzed the numbers of completed
questionnaires and the interassessment intervals in the first 2
years of the Dutch MS study regarding two low-frequency long
questionnaires (MSIP, MSQoL-54) and one high-frequency
short questionnaire (MA).
Principal Findings
First, we found that about 56% of the patients completed the
two long questionnaires at all five 6-month time points (MSIP:
56.8%, MSQoL-54: 55.5%); and second, that about 54% of the
patients completed the short questionnaire at all 25 monthly
time points. Third, we found that over 90% of the patients who
completed all questionnaires for one type of assessment also
completed all questionnaires for the other type; fourth, that the
number of patients who completed the questionnaires decreased
gradually over time, and, fifth, that the patients who completed
all of the long questionnaires at 6-month intervals in a timely
fashion by far outnumbered the patients who performed all of
the monthly short self-assessments in time (85.5% vs 26%).
So, interestingly, over a 2-year period no difference was found
in completion adherence (completion of all scheduled
assessments) between the two less frequent long questionnaires
and a more frequent short questionnaire. This was so despite
the evident differences in patient burden: the short MA
questionnaire had to be completed 5 times more frequently than
the long MSIP and MSQoL-54, and the completion time of the
latter was 6 to 9 times longer than that of the MA questionnaire.
This suggests that completion adherence is influenced not so
much by quantitative aspects like frequency of assessments and
completion time but other factors. These factors could be the
perceived relevance of the questionnaires’ content and the degree
to which health care providers use the questionnaires’ outcomes
in their disease management.
It may well be that patients’ adherence to the completion of
Web-based questionnaires is influenced by the outcomes’
relevance for the disease management such as decisions on
treatment initiation, continuation, or discontinuation. It is of
note that one of the characteristics of the Dutch MS study is
that patients may give health care professionals access to the
completed questionnaires and the automatically generated scores.
Although we suggested the study participants inform their
neurologists, MS nurses, and other health care professionals
about this option, only 21 patients authorized one or more health
care professionals. Accordingly, we think that the low utilization
of the interactive aspect of the study may also explain why at
2 years about 45% of the patients failed to complete all
questionnaires.
Figure 2 suggests that the number of patients who completed
the short monthly MA questionnaire at a given time point
decreased on average by 2.4% per month, an exception being
the decrease of 7.6% at the first interval. Remarkably, the
decrease over time in the number of patients who completed
the 6-month long questionnaires fits in with the pattern of
decreasing completions of the MA questionnaire. There was
another interesting observation: the less frequent long and more
frequent short questionnaires showed almost identical
completion percentages at M6, M12, M18, and M24. In
combination with the fact that more than 90% of the patients
who were completion adherent for one type of assessment were
also completion adherent for the other type and the quasi-linear
decrease in the number of completion adherent patients for both
types of assessment, this observation suggests that nonadherent
patients completed virtually all scheduled questionnaires up to
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a certain time point, at which they decided not to complete any
more questionnaires. From patients’ phone calls to the help desk
it became clear, rather unexpectedly, that participants were
sometimes reluctant to complete the monthly MA questionnaire
because no changes in medication occurred over longer periods
or because they felt ‘spied on’ by the frequent assessments. It
may therefore be hypothesized that a reluctance to complete
one specific questionnaire may have affected not only the
completion of that particular questionnaire but that of the other
questionnaires as well.
Differences between the two types of assessment were found
for interval adherence. Whereas the majority (85.5%) of patients
were interval adherent for the low-frequency long
questionnaires, only a minority (26%) was so for the
high-frequency short questionnaire. The nonadherence in the
latter group was mainly because of the fact that approximately
3 out of 4 patients (73.9%) exceeded the maximum
interassessment interval of 30+6 days at least once and less so
to 4 out of 10 (38.5%) patients performing the M24 assessment
later than 30 days after the scheduled date. This difference in
interval adherence may relate to the difference in assessment
frequencies, as less frequent assessments lower the risk of one
assessment exceeding the maximum interassessment interval.
The difference may also be due to the predefined criteria for
interval adherence: the allowed time window of 6 days for the
monthly completions may have been too narrow for patients
who, for example, because of an MS relapse or a concomitant
disease, were temporarily unable to complete questionnaires.
When comparing the intervals for the consecutive time points,
no consistent differences were found between the MSQoL-54,
MSIP, and MA questionnaires.
It was found that patients with the ability to walk about 100 to
200 m without aid and fully/severely impaired in performing
daily activities (EDSS 5.0 or 5.5) were five times more
completion adherent for the more frequent short questionnaire
than patients with no or minimal disability (EDSS 0 to 2.5). We
speculate that this may relate to the former patients being more
housebound and thus possibly having more time at their disposal
and the latter being more involved in familial, professional, and
societal activities with less time for or interest in the regular
completion of questionnaires. However, at higher EDSS scores
(6.0 and higher), this association was not found, which could
relate to the circumstance that cognitive and physical disabilities
prevented these patients from performing moderately demanding
tasks.
Interestingly, patients who—within 6 months after completion
of the first questionnaire—had their disability assessed by an
experienced MS nurse via phone were almost twice as likely to
be completion adherent for the high-frequency short
questionnaire than were those whose EDSS score was assessed
later. This observation suggests that an early personal contact
between the patient and a member of the research team—with
the opportunity to ask questions about the study or about
individual health status—may positively influence adherence
to an assessment schedule.
Comparison to Prior Work
Whereas a first experience has been reported with
direct-to-patient recruitment for enrollment into clinical trials
[25], to our knowledge no studies have investigated the
adherence to Web-based assessments in long-term
direct-to-patient research. In general, early discontinuation of
study participation has been associated with various
sociodemographic and health-related factors such as being male
[26], black [27], having cognitive impairment [28,29], and
experiencing difficulties in activities of daily living [28]. We
did not find differences in completion or interval adherence
between males and females. Our finding that patients with
moderately high disability were more completion adherent for
the frequent short questionnaire than were patients with no or
minimal disability does not contradict a previous report on
higher dropout rates in very ill persons. In MS patients, disability
mostly results from impaired mobility and not from deficiencies
in general health.
In this study, 64.0% of the patients had completed all monthly
MA questionnaires 1 year after baseline. In a previous 1-year
study in MS patients who started daily glatiramer acetate
treatment, we found that 75.5% of the patients completed all
monthly short questionnaires on fatigue (five items) and HRQoL
(eight items) [12]. This higher percentage could relate to the
content of the questionnaires: fatigue is a frequent and often
debilitating symptom in MS that was expected to improve during
glatiramer acetate treatment, whereas the documentation of
medication and missed DMD doses may be less appealing to
patients. Moreover, in the glatiramer acetate study, patients were
included by their treating neurologists at the time of treatment
initiation, whereas in this study, patients enrolled themselves
at an arbitrary point in time. Nonetheless, the median monthly
interassessment intervals (30-32 days) and the median
baseline-M24 interval ([2x365]+19 days) in this study compare
favorably with the median interassessment intervals (32-34
days) and the median baseline-M12 interval (365+52 days) in
our previous study [12].
Limitations
Our study has several limitations. First, we analyzed data from
a study that was not primarily designed to (also) investigate the
adherence to assessment schedules. Second, by comparing the
adherence to low-frequency long questionnaires with adherence
to a high-frequency short questionnaire, we investigated two
variables simultaneously, and we therefore cannot identify the
relative contribution of a questionnaire’s frequency and length
to the adherence. Third, we confined ourselves to the analysis
of formal aspects of the questionnaires and did not consider
their content, so it may well be that irrespective of the
assessment frequency, patients experienced questions about
(perceived) disabilities (MSIP) as more disturbing and less
motivating than questions about DMD adherence. Fourth,
although the fairly even distribution of the Dutch MS study
participants throughout the Netherlands suggests that the study
group is representative of the Dutch MS population, this has
not been demonstrated; moreover, relatively healthy information
technology users and enthusiasts may be overrepresented in the
study group. Fifth, in view of the direct-to-patient study design,
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we did not verify the MS diagnosis with the patients’
neurologists or whether the diagnosis was made according to
the latest criteria.
As to the instruments we used, it is important to note that the
e-versions of the questionnaires have not been validated. There
is, however, a vast amount of literature showing that e-versions
of questionnaires and scales are equivalent to paper-and-pencil
versions and that both can be used interchangeably. This has
been demonstrated, among others, for questionnaires about
disability [30], symptoms [31,32], HRQoL [33,34],
psychopathology [31,35,36], and psychology [37]. Against this
background we thought it reasonable to apply e-versions of the
MSIP, MSQoL-54, and the MA questionnaire. Moreover, should
any discrepancies exist between paper and e-version of these
questionnaires, these will be of minor relevance as we
consequently used the e-versions throughout the study. As to
the EDSS assessment, the scoring via interview by phone has
been validated for serial assessments in research settings, but
it is not interchangeable with the physician-derived EDSS,
especially for the lower range of disability [22].
Finally, our definitions of completion and interval adherence
were based on what we considered both realistic from a patient
perspective and desirable from the researcher’s point of view.
To be qualified as completion adherent, we required patients to
have completed all the questionnaires. Yet, the completion of
five long questionnaires may be easier for patients to realize
than the completion of 25 short questionnaires over the same
time period. Additionally, from a research perspective, it may
be questioned whether the missing of 1 out 5 or even 1 out of
25 assessments substantially hampers the data quality. Moreover,
the time windows for interval adherence used by us are debatable
and, in general, criteria for interval adherence will depend on
the phenomenon under study and the time span covered by a
questionnaire.
Conclusions
In analyzing the 2-year adherence to self-assessments in the
direct-to-patient Dutch MS study, we found no differences in
completion adherence (completion of all scheduled
questionnaires) between the two low-frequency long
questionnaires versus the high-frequency short questionnaire;
however, the interval adherence (completion of questionnaires
within predefined time frames) was considerably higher for the
low-frequency long questionnaires. Moreover, patients with
moderately high disability were more likely to be completion
adherent for the high-frequency short questionnaire than patients
with no or minimal disability, as were the patients who within
6 months after completion of the first questionnaire had their
disability assessed by an experienced MS nurse via phone in
comparison with those who had their assessment later. The latter
observation may suggest that in Web-based direct-to-patient
research, personal contact with a member of the research team
or feedback on a clinically relevant, professionally reported
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